Interests > Health & Fitness

Coronavirus Events Timeline and InfoDump

(1/3) > >>

SVPete:
Since the MSM are token-covering and memory-holing significant events:

China informed WHO of the outbreak in Wuhan of unknown cause: December 31, 2019, https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/

Covid-19 identified to WHO: January 11 and 12, 2020, https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

China/WHO claims no evidence of  human to human transmission of corona virus: January 14, 2020, https://twitter.com/WHO/status/1217043229427761152

--- Quote ---World Health Organization (WHO)
@WHO
Jan 14
Preliminary investigations conducted by the Chinese authorities have found no clear evidence of human-to-human transmission of the novel #coronavirus (2019-nCoV) identified in #Wuhan, #China.
--- End quote ---

The US started screening arriving passengers from China: January 17, 2020, JFK, SFO, LAX https://www.businessinsider.com/new-disease-virus-china-us-airports-screening-cdc-2020-1 ; O'Hare and Hartsfield-Jackson January 22, 2020, https://www.washingtonpost.com/nation/2020/01/21/us-screenings-coronavirus-expanded-airports-atlanta-chicago/

Pharmaceuticals company working with US government to develop vaccine: January 22, 2020, Moderna, https://www.cnbc.com/2020/01/22/moderna-is-working-on-a-vaccine-for-chinas-deadly-coronavirus.html

Wuhan and other cities in Hubei Province shut down travel: January 23, 2020, https://news.cgtn.com/news/2020-01-27/5-million-people-left-Wuhan-before-the-lockdown-where-did-they-go--NACCu9wItW/index.html

US personnel evacuated from Wuhan: January 29, 2020 https://abcnews.go.com/US/us-chartering-evacuation-flight-wuhan-coronavirus-zone-california/story?id=68571310

State Department raised the travel advisory for China to Level 4, do not travel: January 31, 2020, https://www.usatoday.com/story/travel/2020/01/31/coronavirus-china-flight-ban-delta-cuts-all-flights-white-house/4620989002/

Trump declared a public health emergency: January 31, 2020, https://abcnews.go.com/Health/delta-suspends-us-flights-china-amid-coronavirus/story?id=68666037

People entering the US from China forbidden: Announced January 31, 2020, effective February 2, 2020, https://www.cnn.com/2020/02/02/us/coronavirus-us-travel-restrictions/index.html This effectively ended flights from and to China, for obvious reasons. The current date for flights to resume is March 30, 2020.

An NIH clinical trial of Remdesivir begun: February 25, 2020, at University of Nebraska Medical Center, https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins

Experimental vaccine submitted for testing: February 26, 2020, Moderna, https://www.cnn.com/2020/02/25/business/moderna-coronavirus-vaccine/index.html

Testing labs allowed to use tests whose FDA Emergency Use Authorization requests are still pending: February 29, 2020, https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics

Army signed agreement with Gilead on experimental COVID-19 treatment: March 10, 2020, https://www.militarytimes.com/news/your-military/2020/03/10/army-signs-agreement-with-drug-giant-gilead-on-experimental-covid-19-treatment/

OyaGen, Inc. announced experimental treatment has been studied by National Institute of Allergy and Infectious Diseases: 3/10/2020, http://www.oyageninc.com/wordpress/wp-content/uploads/2020/03/OyaGen-Press-for-03102020.pdf , "OYA1", not yet tested on humans

Eli Lilly announced partnership with research company to develop a treatment/vaccine as part of the DARPA program: March 13, 2020, https://www.msn.com/en-us/finance/companies/eli-lilly-joins-race-to-develop-coronavirus-treatment/ar-BB116BNR

Trump declared National Emergency: March 13, 2020, https://www.msn.com/en-us/news/politics/what-trumps-emergency-declaration-over-coronavirus-means-for-arizona/ar-BB11a6RO

Testing begins of Moderna's experimental coronavirus vaccine: March 16, 2020, at Kaiser Permanente Washington Health Research Institute, https://www.kpwashingtonresearch.org/news-and-events/recent-news/news-2020/kaiser-permanente-launches-coronavirus-vaccine-study-seattle

SVPete:
Just for clarity regarding two terms in the article below, "Treatments" would be for people sick with Covid-19, and "Vaccines" would be for preventing people getting infected. Thus, treatments are the more immediate need. That said:

https://www.statnews.com/2020/03/02/coronavirus-drugs-and-vaccines-in-development/

A detailed guide to the coronavirus drugs and vaccines in development
By DAMIAN GARDE // MARCH 2, 2020


--- Quote ---Here’s a guide to some of the most talked-about efforts to treat or prevent coronavirus infection, with details on the science, history, and timeline for each endeavor.

Gilead Sciences
Approach: Treatment
Stage: Phase 3
...
Moderna Therapeutics
Approach: Vaccine
Stage: Phase 1
...
CureVac
Approach: Vaccine
Stage: Preclinical
...
GlaxoSmithKline
Approach: Vaccine
Stage: Preclinical
...
Inovio Pharmaceuticals
Approach: Vaccine
Stage: Preclinical
...
Johnson & Johnson
Approach: Vaccine and treatment
Stage: Preclinical
...
Regeneron Pharmaceuticals
Approach: Treatment
Stage: Preclinical
...
Sanofi
Approach: Vaccine
Stage: Preclinical
...
Vir Biotechnology
Approach: Treatment
Stage: Preclinical
--- End quote ---

There is an Israeli firm whose experimental vaccine isn't on that list, https://www.jpost.com/HEALTH-SCIENCE/Israeli-scientists-In-three-weeks-we-will-have-coronavirus-vaccine-619101 .

SVPete:
https://spectrum.ieee.org/the-human-os/biomedical/bionics/darpas-firebreak-treatment-for-the-coronavirus
By Eliza Strickland // 05 Mar 2020 | 17:00 GMT

DARPA Races To Create a "Firebreak" Treatment for the Coronavirus


--- Quote ---When DARPA launched its Pandemic Preparedness Platform (P3) program two years ago, the pandemic was theoretical. It seemed like a prudent idea to develop a quick response to emerging infectious diseases. Researchers working under the program sought ways to confer instant (but short-term) protection from a dangerous virus or bacteria.

Today, as the novel coronavirus causes a skyrocketing number of COVID-19 cases around the world, the researchers are racing to apply their experimental techniques to a true pandemic playing out in real time. “Right now, they have one shot on goal,” says DARPA program manager Amy Jenkins. “We’re really hoping it works.”

The P3 program’s plan was to start with a new pathogen and to “develop technology to deliver medical countermeasures in under 60 days—which was crazy, unheard of,” says Jenkins. The teams have proven they can meet this ambitious timeline in previous trials using the influenza and Zika viruses. Now they’re being asked to pull off the same feat with the new coronavirus, which more formally goes by the name SARS-CoV-2 and causes the illness known as COVID-19.
--- End quote ---

SVPete:
https://www.militarytimes.com/news/your-military/2020/03/10/army-signs-agreement-with-drug-giant-gilead-on-experimental-covid-19-treatment/

Army signs agreement with drug giant Gilead on experimental COVID-19 treatment


--- Quote ---U.S. Army Medical Research and Development Command has signed an arrangement with Gilead Sciences to provide the company’s investigational coronavirus drug to U.S. troops confirmed to have the COVID-19 virus.

Gilead’s medication, remdesivir, was approved for clinical research in February by the Food and Drug Administration. The medication, which initially was developed by the Foster City, California-based company to treat Ebola, has had some demonstrated success targeting coronaviruses, including Middle East Respiratory Syndrome, or MERS, and Severe Acute Respiratory Syndrome, SARS.

The medicine, given intravenously, is currently being tested for safety and effectiveness in two separate clinical trials in China and one by the National Institute of Allergy and Infection Diseases. In the U.S. study, the first volunteer was an evacuee from the Diamond Princess cruise ship hospitalized with the illness at the University of Nebraska Medical Center in Omaha.
--- End quote ---

SVPete:
https://www.msn.com/en-us/finance/companies/eli-lilly-joins-race-to-develop-coronavirus-treatment/ar-BB116BNR

Eli Lilly Joins Race to Develop Coronavirus Treatment
3/13/2020

--- Quote ---(Bloomberg) -- Pharmaceutical giant Eli Lilly & Co. has entered an agreement to develop an experimental therapy for the new coronavirus with with closely held biotechnology company AbCellera Biologics Inc.

The Vancouver based biotechnology firm is already working on discovering antibodies that could potentially be deployed to stop transmission of the virus and prevent the lung illness known as Covid-19.
...
A roundtable of pharmaceutical executives told U.S. President Donald Trump this month that antiviral medications could be available for patients in a matter of months. Vaccines, which would prevent healthy people from contracting the disease, are further from reaching doctors’ offices and pharmacy shelves. Gilead Sciences Inc. and AbbVie Inc. have emerged as front-runners for potential treatments for the disease, while Sanofi, Johnson & Johnson and Moderna Inc. are developing vaccines. No executives from Lilly attended the White House meeting.

Lilly’s success in fighting the novel coronavirus will be dependent on AbCellera, which has developed propriety technology that quickly screens for potent antibodies and validates potential candidates on tight timelines. The discovery company touts its ability to “fast-track” drug programs for its many partners, which have included major pharmaceutical companies like Pfizer Inc., Merck & Co. and Sanofi.

AbCellera is no stranger to pandemic response. In 2018, the company was awarded a contract from the U.S. Department of Defense’s Defense Advanced Research Projects Agency, or Darpa, for as much as $30 million in funding to create an end-to-end platform for rapid pandemic response. ...
--- End quote ---

Navigation

[0] Message Index

[#] Next page